SARS-CoV-2 Variants and Vaccines.
Krause PR., Fleming TR., Longini IM., Peto R., Briand S., Heymann DL., Beral V., Snape MD., Rees H., Ropero A-M., Balicer RD., Cramer JP., Muñoz-Fontela C., Gruber M., Gaspar R., Singh JA., Subbarao K., Van Kerkhove MD., Swaminathan S., Ryan MJ., Henao-Restrepo A-M.
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.